Absorption, Metabolism, and Disposition of [14C]SDZ ENA 713, an Acetylcholinesterase Inhibitor, in Minipigs Following Oral, Intravenous, and Dermal Administration

被引：0

作者：

Francis L. S. Tse

Robert Laplanche

机构：

[1] Novartis Pharmaceuticals Corporation,Department of Drug Metabolism and Pharmacokinetics, Preclinical Safety

[2] Preclinical Safety,Department of Drug Metabolism and Pharmacokinetics

[3] Novartis Pharma Inc.,undefined

来源：

Pharmaceutical Research | 1998年 / 15卷

关键词：

Alzheimer's disease; rivastigmine; minipig; transdermal absorption; bioavailability; skin abrasion;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Purpose. SDZ ENA 713 (rivastigmine) is an acetylcholinesterase inhibitor intended for therapeutic use in Alzheimer's disease. The present study compared the pharmacokinetics of [14C]SDZ ENA 713 after intravenous, oral, and dermal administration to male minipigs, and also examined the effects of dose level and skin abrasion on transdermal absorption.

引用

页码：1614 / 1620

页数：6

共 50 条

[31] Disposition of [14C]-polystyrene microplastics after oral administration to lactating sheep
Shelver, Weilin L.
McGarvey, Amy M.
Billey, Lloyd O.
[J]. FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT, 2024, 41 (09): : 1132 - 1143
[32] Absorption, disposition, metabolism and excretion of [14C]mizagliflozin, a novel selective SGLT1 inhibitor, in rats
Ohno, Hitoshi
Kojima, Yasunari
Harada, Hiroshi
Abe, Yoshikazu
Endo, Takuro
Kobayashi, Mamoru
[J]. XENOBIOTICA, 2019, 49 (04) : 463 - 473
[33] Metabolism and Disposition of [14C]BMS-690514, an ErbB/Vascular Endothelial Growth Factor Receptor Inhibitor, after Oral Administration to Humans
Christopher, Lisa J.
Hong, Haizheng
Vakkalagadda, Blisse J.
Clemens, Pamela L.
Su, Hong
Roongta, Vikram
Allentoff, Alban
Sun, Haojun
Heller, Kevin
Harbison, Christopher T.
Iyer, Ramaswamy A.
Humphreys, William G.
Wong, Tai
Zhang, Steven
[J]. DRUG METABOLISM AND DISPOSITION, 2010, 38 (11) : 2049 - 2059
[34] Absorption, Distribution and Excretion of [14C] Zamicastat after Single Oral and Intravenous Administration in Rats and Dogs
Loureiro, Ana
Araujo, Francisca
Bonifacio, Maria-Joao
[J]. FASEB JOURNAL, 2020, 34
[35] Pharmacokinetics, metabolism and excretion of [14C]-lenalidomide following oral administration in healthy male subjects
Nianhang Chen
Lian Wen
Henry Lau
Sekhar Surapaneni
Gondi Kumar
[J]. Cancer Chemotherapy and Pharmacology, 2012, 69 : 789 - 797
[36] Pharmacokinetics, metabolism and excretion of [14C]-lenalidomide following oral administration in healthy male subjects
Chen, Nianhang
Wen, Lian
Lau, Henry
Surapaneni, Sekhar
Kumar, Gondi
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 789 - 797
[37] Disposition of arsenobetaine in two marine fish species following administration of a single oral dose of [14C]arsenobetaine
Amlund, Heidi
Ingebrigtsen, Kristian
Hylland, Ketil
Ruus, Anders
Eriksen, Dag Oistein
Berntssen, Marc H. G.
[J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2006, 143 (02): : 171 - 178
[38] COMPARISON OF CEREBRAL REGIONAL METABOLISM OF [14C]LEUCINE FOLLOWING THIRD VENTRICLE AND INTRAVENOUS ADMINISTRATION IN CAT
BERL, S
FRIGYESI, TL
[J]. JOURNAL OF NEUROCHEMISTRY, 1969, 16 (03) : 405 - +
[39] Absorption, distribution, metabolism, and excretion of [14C]TPN729 after oral administration to rats
Cheng, Huan
Yu, Jinghua
Yang, Chen
Zhang, Ning
Fan, Zhen
Zhang, Xiaojuan
Wang, Junchen
Wang, Zhen
Zhong, Da-Fang
He, Ji-Xiang
Yan, Shu
Diao, Xingxing
[J]. XENOBIOTICA, 2022, 52 (01) : 79 - 90
[40] Pharmacokinetics and metabolism of [14C]eplerenone after oral administration to humans
Cook, CS
Berry, LM
Bible, RH
Hribar, JD
Hajdu, E
Liu, NW
[J]. DRUG METABOLISM AND DISPOSITION, 2003, 31 (11) : 1448 - 1455

← 1 2 3 4 5 →